# India to Start Human Trials for Medicinal Cannabis > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/india-medicinal-cannabis-trials-human-research-launch/ > **Published:** 2026-02-26T10:18:40-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:13:56-04:00 > **Clinical Summary:** India medicinal cannabis trials begin, aiming to generate safety and efficacy data to support regulatory acceptance and patient access in Asia. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchPolicySafetyDosingPain Why This Matters If India’s human trials produce strong safety and efficacy data, it could accelerate regulatory acceptance of medicinal cannabis across South and Southeast Asia, potentially expanding patient access in regions where options are currently very limited. Clinical Summary India’s launch of human [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) for medicinal cannabis represents a significant regulatory and scientific shift for a country with historically strict drug policies. These trials will generate controlled safety and efficacy data across specific medical conditions, helping to establish evidence-based frameworks for potential therapeutic use. Structured human trials are essential for understanding dosing, pharmacokinetics, and therapeutic windows in diverse patient populations, and data from a large and genetically diverse country like India could meaningfully contribute to global [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) research. Dr. Caplan’s Take “Rigorous human trial data from a population this large and diverse could finally give the global medical community the controlled evidence it needs to move cannabis medicine out of the anecdote era and into standard clinical guidelines.” Clinical Perspective India’s initiation of human trials for medicinal cannabis represents a significant shift in global cannabis research, particularly given the country’s historical restrictions on the plant. Expanding clinical trials in diverse populations and healthcare systems strengthens the evidence base for [cannabis-derived therapeutics](https://cedclinic.com/cannabis-related-regulatory-documents-dea/) and helps identify which patient populations may benefit most. These trials will be crucial for establishing safety and efficacy data that can inform regulatory pathways in other countries still evaluating cannabis medicine. International collaboration and shared research findings accelerate our collective understanding of cannabinoid pharmacology and optimal clinical applications. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+%3Cb%3ECannabis+research%3C%2Fb%3E%3A+India+to+start+human+trials+for+medicinal+marijuana+-+NewsBytes+%40drcaplan&url=https%3A%2F%2Fwww.newsbytesapp.com%2Fnews%2Findia%2Fcannabis-research-india-to-start-human-trials-for-medicinal-marijuana%2Ftldr) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.newsbytesapp.com%2Fnews%2Findia%2Fcannabis-research-india-to-start-human-trials-for-medicinal-marijuana%2Ftldr) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+%3Cb%3ECannabis+research%3C%2Fb%3E%3A+India+to+start+human+trials+for+medicinal+marijuana+-+NewsBytes+%E2%80%94+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.newsbytesapp.com%2Fnews%2Findia%2Fcannabis-research-india-to-start-human-trials-for-medicinal-marijuana%2Ftldr) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.newsbytesapp.com/news/india/cannabis-research-india-to-start-human-trials-for-medicinal-marijuana/tldr](https://www.newsbytesapp.com/news/india/cannabis-research-india-to-start-human-trials-for-medicinal-marijuana/tldr) Further Reading CED Clinic Blog[5 Exciting Insights from the MedCan 3 Trial](https://cedclinic.com/medcan3-trial-cancer-symptoms/)Evidence Watch[Regulatory Digest 2026-03-08](https://cedclinic.com/regulatory-digest-2026-03-09/)Policy Watch[Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I](https://cedclinic.com/dea-temporary-placement-schedule-i-n-desethyl-isotonitazene/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Does marijuana work as medicine? Clinical trials aim to find answers.](https://cedclinic.com/clinical-trials-cannabis-efficacy-new-evidence/) Explore how clinical trials are investigating the medicinal benefits and safety of marijuana to provide evidence-based treatment options. [Learn about clinical trials](https://cedclinic.com/clinical-trials-cannabis-efficacy-new-evidence/) [Missouri sets sights on establishing licensed cannabis research](https://cedclinic.com/state-licensed-cannabis-research-frameworks-missouri/) Missouri's efforts to create licensed cannabis research programs highlight the growing importance of regulated clinical studies. [Read about Missouri research](https://cedclinic.com/state-licensed-cannabis-research-frameworks-missouri/) [Trump’s reclassification move on marijuana could boost medical research – C&EN](https://cedclinic.com/cannabis-schedule-i-reclassification-research-impact/) Understand how policy changes in the US may expand research opportunities and influence global cannabis medicine development. [Explore policy impacts](https://cedclinic.com/cannabis-schedule-i-reclassification-research-impact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).